GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+15.7%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$97M
AUM Growth
+$97M
(-11%)
Cap. Flow
-$19.7M
Cap. Flow
% of AUM
-20.34%
Top 10 Holdings %
Top 10 Hldgs %
36.82%
Holding
90
New
29
Increased
10
Reduced
15
Closed
26
Top Buys
| 1 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$3.72M |
| 2 |
CHTP
CHELSEA THERAPEUTICS INT'L LTD
CHTP
|
$2.76M |
| 3 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$2.64M |
| 4 |
Merit Medical Systems
MMSI
|
$2.5M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$2.41M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$10.1M |
| 2 |
SPNC
Spectranetics Corp
SPNC
|
$3.79M |
| 3 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$3.44M |
| 4 |
MZOR
Mazor Robotics Ltd.
MZOR
|
$3.42M |
| 5 |
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
|
$3.34M |
Sector Composition
| 1 | Healthcare | 78.03% |
| 2 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Sangamo Therapeutics
SGMO
$157M
| $1.57M | 0.93% | 86,606 -63,394 | -42% | -$1.15M |
|
|
NSTG
27
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.55M | 0.92% | +75,000 | New | +$1.55M |
|
|
SPNC
28
DELISTED
Spectranetics Corp
SPNC
| $1.52M | 0.9% | 50,000 -125,000 | -71% | -$3.79M |
|
29
Illumina
ILMN
$15.8B
| $1.49M | 0.88% | +10,000 | New | +$1.49M |
|
|
GWPH
30
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $1.48M | 0.88% | +25,000 | New | +$1.48M |
|
31
Assertio
ASRT
$80.4M
| $1.45M | 0.86% | 100,000 +50,000 | +100% | +$725K |
|
|
LCI
32
DELISTED
Lannett Company, Inc.
LCI
| $1.43M | 0.85% | 40,000 -20,000 | -33% | -$715K |
|
33
Enanta Pharmaceuticals
ENTA
$180M
| $1.4M | 0.83% | +35,000 | New | +$1.4M |
|
34
TherapeuticsMD
TXMD
$12.8M
| $1.26M | 0.75% | +200,000 | New | +$1.26M |
|
35
Puma Biotechnology
PBYI
$254M
| $1.18M | 0.7% | 11,330 -13,670 | -55% | -$1.42M |
|
|
NUVA
36
DELISTED
NuVasive, Inc.
NUVA
| $1.15M | 0.68% | +30,000 | New | +$1.15M |
|
|
EPZM
37
DELISTED
Epizyme, Inc
EPZM
| $1.03M | 0.61% | +45,000 | New | +$1.03M |
|
|
KYTH
38
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $994K | 0.59% | +25,000 | New | +$994K |
|
|
ATRS
39
DELISTED
Antares Pharma, Inc.
ATRS
| $875K | 0.52% | +250,000 | New | +$875K |
|
|
TEAR
40
DELISTED
TearLab Corporation
TEAR
| $845K | 0.5% | 125,000 -50,000 | -29% | -$338K |
|
|
NXTM
41
DELISTED
NxStage Medical Inc.
NXTM
| $796K | 0.47% | 62,500 -62,500 | -50% | -$796K |
|
|
ETRM
42
DELISTED
EnteroMedics Inc.
ETRM
| $728K | 0.43% | +400,000 | New | +$728K |
|
|
BIOL
43
DELISTED
Biolase, Inc.
BIOL
| $723K | 0.43% | +300,000 | New | +$723K |
|
|
FLXN
44
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $658K | 0.39% | +40,000 | New | +$658K |
|
|
RVNC
45
DELISTED
Revance Therapeutics, Inc.
RVNC
| $630K | 0.37% | +20,000 | New | +$630K |
|
|
AMRN
46
Amarin Corp
AMRN
$311M
| $543K | 0.32% | +300,000 | New | +$543K |
|
47
Novavax
NVAX
$1.21B
| $453K | 0.27% | +100,000 | New | +$453K |
|
48
Catalyst Pharmaceutical
CPRX
$2.52B
| $452K | 0.27% | 200,000 +25,000 | +14% | +$56.5K |
|
49
Dynavax Technologies
DVAX
$1.19B
| $447K | 0.27% | 247,340 -102,660 | -29% | -$186K |
|
|
ANAC
50
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $400K | 0.24% | +20,000 | New | +$400K |
|